跳至主要内容
临床试验/NCT01046669
NCT01046669已完成不适用

Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock

Spectral Diagnostics (US) Inc.40 个研究点 分布在 2 个国家目标入组 450 人开始时间: 2010年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
450
试验地点
40
主要终点
Mortality

研究概览

简要总结

To compare the safety and efficacy of the PMX cartridge based on mortality at 28-days in subjects with septic shock who have high levels of endotoxin and are treated with standard medical care plus use of the PMX cartridge, versus subjects who receive standard medical care alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypotension requiring vasopressor support
  • The subject must have received intravenous fluid resuscitation
  • Documented or suspected infection
  • Endotoxin Activity Assay ≥ 0.60 EAA units
  • Evidence of at least 1 new onset organ dysfunction

排除标准

  • Inability to achieve or maintain a minimum mean arterial pressure (MAP) of 65mmHg
  • Subject has end stage renal disease and requires chronic dialysis
  • There is clinical support for non-septic shock
  • Subject has had chest compressions as part of CPR
  • Subject has had an acute myocardial infarction (AMI)
  • Subject has uncontrolled hemorrhage
  • Major trauma within 36 hours of screening
  • Subject has severe granulocytopenia
  • HIV infection with a last known or suspected CD4 count of <50/mm3
  • Subject has sustained extensive third-degree burns
  • Body weight < 35 kg (77 pounds)
  • Known hypersensitivity to polymyxin B
  • Subject has known sensitivity or allergy to heparin
  • Subject has screening MOD score of ≤9

研究组 & 干预措施

Control

Sham Comparator

Standard medical care for septic shock

干预措施: Standard medical care for septic shock (Other)

Treatment

Experimental

Two (2) PMX cartridges will be administered approximately 24 hours apart plus standard medical care for septic shock

干预措施: TORAYMYXIN PMX-20R (PMX cartridge) (Device)

Treatment

Experimental

Two (2) PMX cartridges will be administered approximately 24 hours apart plus standard medical care for septic shock

干预措施: Standard medical care for septic shock (Other)

结局指标

主要结局

Mortality

时间窗: 28 days

Compare mortality at 28 days in subjects treated with standard medical care plus PMX cartridge, versus subjects who received standard medical care alone

次要结局

未报告次要终点

研究者

发起方
Spectral Diagnostics (US) Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (40)

Loading locations...

相似试验

Safety and Efficacy of Polymyxin B Hemoperfusion... | 临床试验